This position is bugeted for $5,720.00 - $6,200.00 per month and is non-negotiable.
We are seeking a highly motivated postdoctoral researcher to join the laboratory of Dr. Dwayne Roach at San Diego State University (SDSU). This NIH-funded position focuses on the development, mechanistic dissection, and translational advancement of bacteriophage therapy for Pseudomonas aeruginosa, a high-priority pathogen in antimicrobial resistance. The Roach lab integrates in vivo infection models, phage engineering, microbial genomics, and host-pathogen interaction studies to improve the design and application of therapeutic phages.
The position offers broad engagement across both preclinical and translational domains. In addition to mechanistic research, the postdoc will gain direct experience with therapeutic development workflows, spanning early-stage discovery through compassionate use applications in individual patients. SDSU is a R1 research institution with expanding investment in microbiology and translational biomedical research. The Roach lab maintains active collaborations across the San Diego research ecosystem, including UC San Diego, and regional clinical centers, offering a rich environment for interdisciplinary work and professional development.
For questions about the position, contact Dwayne Roach at dwayne.roach@sdsu.edu
Lab Website: http://www.phagebio.org
Research Focus
This position centers on the in vivo performance and translational development of bacteriophage therapy targeting P. aeruginosa. The postdoc will lead studies to define the pharmacokinetics and pharmacodynamics of therapeutic phages using murine models of pulmonary and systemic infection. These experiments will evaluate how phages distribute through host tissues, persist over time, and reduce bacterial burden across varied dosing strategies. A parallel effort will examine how P. aeruginosa adapts to phage pressure in vivo and how resistance mechanisms impact therapeutic durability.
The project includes analysis of host responses to phage therapy, including innate immune activation, barrier disruption, and inflammation. These studies will integrate transcriptomic, genomic, and tissue-level approaches to identify host and microbial features associated with treatment outcomes. Insights from this work will guide the design of engineered phages with broader host range, improved resistance evasion, and reduced immunogenicity to enhance therapeutic performance in vivo.
A core translational component of this position involves direct participation in compassionate use phage therapy. The postdoc will work with clinical partners to identify and characterize phages for patient-specific treatment and perform phage–pathogen matching. Manufacturing is performed in-house, providing hands-on exposure to production and quality control workflows.
This role offers a rare opportunity to integrate basic research with real-time clinical application.
This is a hypothesis-driven position with strong opportunities for scientific independence, translational impact, and interdisciplinary collaboration within a rapidly evolving research environment.
Minimum Education
PREFERRED QUALIFICATIONS AND SPECIAL SKILLS
ADDITIONAL APPLICANT INFORMATION
Software Powered by iCIMS
www.icims.com